165 related articles for article (PubMed ID: 31460362)
1.
Li H; Zhang X; Wu HY; Sun L; Ma Y; Xu J; Lin Q; Zeng D
ACS Omega; 2019 Jul; 4(7):12432-12437. PubMed ID: 31460362
[TBL] [Abstract][Full Text] [Related]
2. A Pretargeted Imaging Strategy for Immune Checkpoint Ligand PD-L1 Expression in Tumor Based on Bioorthogonal Diels-Alder Click Chemistry.
Qiu L; Tan H; Lin Q; Si Z; Mao W; Wang T; Fu Z; Cheng D; Shi H
Mol Imaging Biol; 2020 Aug; 22(4):842-853. PubMed ID: 31741201
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of N-[(11)C]methyl-AMD3465 as a PET tracer for imaging of CXCR4 receptor expression in a C6 glioma tumor model.
Hartimath SV; van Waarde A; Dierckx RA; de Vries EF
Mol Pharm; 2014 Nov; 11(11):3810-7. PubMed ID: 25094028
[TBL] [Abstract][Full Text] [Related]
4. Pretargeted PET of Osteodestructive Lesions in Dogs.
Maitz CA; Delaney S; Cook BE; Genady AR; Hoerres R; Kuchuk M; Makris G; Valliant JF; Sadeghi S; Lewis JS; Hennkens HM; Bryan JN; Zeglis BM
Mol Pharm; 2022 Sep; 19(9):3153-3162. PubMed ID: 35635337
[TBL] [Abstract][Full Text] [Related]
5. Successful Application of CuAAC Click Reaction in Constructing
Lee W; Sarkar S; Pal R; Kim JY; Park H; Huynh PT; Bhise A; Bobba KN; Kim KI; Ha YS; Soni N; Kim W; Lee K; Jung JM; Rajkumar S; Lee KC; Yoo J
ACS Appl Bio Mater; 2021 Mar; 4(3):2544-2557. PubMed ID: 35014372
[TBL] [Abstract][Full Text] [Related]
6.
Li H; Li X; Sun L; He Y; Wang L; Gao Y; Zeng D; Pang X; Xu J
Bioconjug Chem; 2024 May; 35(5):567-574. PubMed ID: 38634516
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the inverse electron demand Diels-Alder reaction in rats using a scandium-44-labelled tetrazine for pretargeted PET imaging.
Edem PE; Sinnes JP; Pektor S; Bausbacher N; Rossin R; Yazdani A; Miederer M; Kjær A; Valliant JF; Robillard MS; Rösch F; Herth MM
EJNMMI Res; 2019 May; 9(1):49. PubMed ID: 31140047
[TBL] [Abstract][Full Text] [Related]
8. Characterization of Structurally Diverse
Adhikari K; Dewulf J; Vangestel C; Van der Veken P; Stroobants S; Elvas F; Augustyns K
ACS Omega; 2023 Oct; 8(41):38252-38262. PubMed ID: 37867688
[No Abstract] [Full Text] [Related]
9. Dual Radionuclide Theranostic Pretargeting.
Keinänen O; Brennan JM; Membreno R; Fung K; Gangangari K; Dayts EJ; Williams CJ; Zeglis BM
Mol Pharm; 2019 Oct; 16(10):4416-4421. PubMed ID: 31483993
[TBL] [Abstract][Full Text] [Related]
10. Optimization of a Pretargeted Strategy for the PET Imaging of Colorectal Carcinoma via the Modulation of Radioligand Pharmacokinetics.
Zeglis BM; Brand C; Abdel-Atti D; Carnazza KE; Cook BE; Carlin S; Reiner T; Lewis JS
Mol Pharm; 2015 Oct; 12(10):3575-87. PubMed ID: 26287993
[TBL] [Abstract][Full Text] [Related]
11. Improved stability of a novel fluorine-18 labeled TCO analogue for pretargeted PET imaging.
Ruivo E; Adhikari K; Elvas F; Fissers J; Vangestel C; Staelens S; Stroobants S; Van der Veken P; Wyffels L; Augustyns K
Nucl Med Biol; 2019; 76-77():36-42. PubMed ID: 31707309
[TBL] [Abstract][Full Text] [Related]
12. Tetrazine Glycoconjugate for Pretargeted Positron Emission Tomography Imaging of
Auchynnikava T; Äärelä A; Liljenbäck H; Järvinen J; Andriana P; Kovacs L; Rautio J; Rajander J; Virta P; Roivainen A; Li XG; Airaksinen AJ
ACS Omega; 2023 Dec; 8(48):45326-45336. PubMed ID: 38075748
[TBL] [Abstract][Full Text] [Related]
13. Preclinical Evaluation of [
Peng T; Wang X; Li Z; Bi L; Gao J; Yang M; Wang Y; Yao X; Shan H; Jin H
Mol Pharm; 2021 Sep; 18(9):3638-3648. PubMed ID: 34424706
[TBL] [Abstract][Full Text] [Related]
14. Preclinical Evaluation of hnRNPA2B1 Antibody in Human Triple-Negative Breast Cancer MDA-MB-231 Cells via PET Imaging.
Bhise A; Park H; Lee W; Sarkar S; Ha YS; Rajkumar S; Nam B; Lim JE; Huynh PT; Lee K; Son JY; Kim JY; Lee KC; Yoo J
Pharmaceutics; 2022 Aug; 14(8):. PubMed ID: 36015303
[TBL] [Abstract][Full Text] [Related]
15. PET Imaging of HER2-Positive Tumors with Cu-64-Labeled Affibody Molecules.
Qi S; Hoppmann S; Xu Y; Cheng Z
Mol Imaging Biol; 2019 Oct; 21(5):907-916. PubMed ID: 30617730
[TBL] [Abstract][Full Text] [Related]
16. Improved metabolic stability for 18F PET probes rapidly constructed via tetrazine trans-cyclooctene ligation.
Selvaraj R; Giglio B; Liu S; Wang H; Wang M; Yuan H; Chintala SR; Yap LP; Conti PS; Fox JM; Li Z
Bioconjug Chem; 2015 Mar; 26(3):435-42. PubMed ID: 25679331
[TBL] [Abstract][Full Text] [Related]
17. Bridged cyclams as imaging agents for chemokine receptor 4 (CXCR4).
Woodard LE; De Silva RA; Behnam Azad B; Lisok A; Pullambhatla M; G Lesniak W; Mease RC; Pomper MG; Nimmagadda S
Nucl Med Biol; 2014 Aug; 41(7):552-61. PubMed ID: 25038987
[TBL] [Abstract][Full Text] [Related]
18. Harnessing
Keinänen O; Fung K; Brennan JM; Zia N; Harris M; van Dam E; Biggin C; Hedt A; Stoner J; Donnelly PS; Lewis JS; Zeglis BM
Proc Natl Acad Sci U S A; 2020 Nov; 117(45):28316-28327. PubMed ID: 33106429
[TBL] [Abstract][Full Text] [Related]
19. Antibody-Based In Vivo Imaging of Central Nervous System Targets-Evaluation of a Pretargeting Approach Utilizing a TCO-Conjugated Brain Shuttle Antibody and Radiolabeled Tetrazines.
Bredack C; Edelmann MR; Borroni E; Gobbi LC; Honer M
Pharmaceuticals (Basel); 2022 Nov; 15(12):. PubMed ID: 36558900
[TBL] [Abstract][Full Text] [Related]
20. Site-specific conjugation allows modulation of click reaction stoichiometry for pretargeted SPECT imaging.
Mandikian D; Rafidi H; Adhikari P; Venkatraman P; Nazarova L; Fung G; Figueroa I; Ferl GZ; Ulufatu S; Ho J; McCaughey C; Lau J; Yu SF; Prabhu S; Sadowsky J; Boswell CA
MAbs; 2018; 10(8):1269-1280. PubMed ID: 30199303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]